Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Addressing Anxiety and Stress for Healthier Eating in Teens (ASSET): A Pilot Randomized Controlled Trial Protocol for Reducing Anxiety, Disinhibited Eating, Excess Weight Gain, and Cardiometabolic Risk in Adolescent Girls.
Repke HE, Gulley LD, Rice AJ, Gallagher-Teske JH, Markos B, Sanchez N, Bristol M, Haynes H, Lavender JM, Higgins Neyland MK, Shank LM, Emerick JE, Gutierrez-Colina AM, Arnold T, Thomas V, Haigney MC, Shomaker LB, Tanofsky-Kraff M. Repke HE, et al. Nutrients. 2022 Oct 12;14(20):4246. doi: 10.3390/nu14204246. Nutrients. 2022. PMID: 36296930 Free PMC article.
Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix.
Campbell P, Gebrael G, Narang A, Chehade CH, Thomas VM, Galarza Fortuna G, Sayegh N, Tripathi N, Tandar C, Dal E, Li H, Swami U, Agarwal N, Maughan BL. Campbell P, et al. Among authors: thomas vm. Ther Adv Urol. 2024 Nov 8;16:17562872241293779. doi: 10.1177/17562872241293779. eCollection 2024 Jan-Dec. Ther Adv Urol. 2024. PMID: 39524157 Free PMC article.
Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations.
Narang A, Gebrael G, Jo Y, Thomas VM, Li H, Fortuna GG, Sayegh N, Tandar C, Tripathi N, Chigarira B, Srivastava A, Hage Chehade C, Nordblad B, Maughan BL, Agarwal N, Swami U. Narang A, et al. Among authors: thomas vm. Kidney Cancer. 2024 Sep 5;8(1):135-142. doi: 10.3233/KCA-240016. eCollection 2024. Kidney Cancer. 2024. PMID: 39263256 Free PMC article.
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor.
Bakaloudi DR, Talukder R, Makrakis D, Diamantopoulos L, Enright T, Leary JB, Patgunarajah U, Thomas VM, Swami U, Agarwal N, Jindal T, Koshkin VS, Brown JR, Barata P, Murgić J, Miletić M, Johnson J, Zakharia Y, Hui G, Drakaki A, Duran I, Buznego LA, Barrera RM, Castañeda DM, Rey-Cárdenas M, Castellano D, Nguyen CB, Park JJ, Alva A, McKay RR, Stewart TF, Epstein IB, Bellmunt J, Wright JL, Gupta S, Grivas P, Khaki AR. Bakaloudi DR, et al. Among authors: thomas vm. Clin Genitourin Cancer. 2024 Dec;22(6):102198. doi: 10.1016/j.clgc.2024.102198. Epub 2024 Aug 12. Clin Genitourin Cancer. 2024. PMID: 39241315
Managing Forests for Biodiversity Conservation and Climate Change Mitigation.
Azuero-Pedraza CG, Lauri P, Lessa Derci Augustynczik A, Thomas VM. Azuero-Pedraza CG, et al. Among authors: thomas vm. Environ Sci Technol. 2024 May 28;58(21):9175-9186. doi: 10.1021/acs.est.3c07163. Epub 2024 May 14. Environ Sci Technol. 2024. PMID: 38743611 Free PMC article.
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
Coletta AM, Simon LH, Maslana K, Taylor S, Larson K, Hansen PA, Thomas VM, Ulrich CM, Kohli M, Chipman J, Swami U, Gupta S, Maughan BL, Agarwal N. Coletta AM, et al. Among authors: thomas vm. BMC Cancer. 2024 Apr 18;24(1):493. doi: 10.1186/s12885-024-12260-3. BMC Cancer. 2024. PMID: 38637770 Free PMC article.
Reply by Authors.
Gebrael G, Sayegh N, Tripathi N, Goel D, McFarland T, Ebrahimi H, Nordblad B, Chigarira B, Thomas VM, Sahu KK, Li H, Chehrazi-Raffle A, Kohli M, Agarwal N, Swami U, Maughan BL. Gebrael G, et al. Among authors: thomas vm. Urol Pract. 2023 Oct 30:101097UPJ000000000000047102. doi: 10.1097/UPJ.0000000000000471.02. Online ahead of print. Urol Pract. 2023. PMID: 37903752 No abstract available.
65 results